Table 4.
Time to Completing an Adequate Evaluation (n=764)*
| Adjusted Hazard Ratio†(95% Confidence Interval) | |
|---|---|
| Age | 0.85 (0.75 to 0.97) |
| Race | |
| White | 1 |
| Latina | 0.78 (0.49 to 1.23) |
| African American | 0.88 (0.62 to 1.24) |
| Asian/Other | 0.97 (0.63 to 1.48) |
| Body mass index (BMI) | |
| Normal | 1 |
| Overweight | 0.90 (0.69 to 1.18) |
| Obese | 0.86 (0.64 to 1.15) |
| Married or living with partner (relative to others) | 1.10 (0.89 to 1.36) |
| Uninsured (relative to insured) | 0.47 (0.24 to 0.93) |
| Breast health risk factors (relative to those without) | |
| History of fibrocystic disease | 1.21 (0.98 to 1.49) |
| Multiple lumps | 1.16 (0.94 to 1.43) |
| Family history | 1.03 (0.79 to 1.34) |
| Prior biopsy | 1.04 (0.84 to 1.28) |
| Nulliparous | 0.87 (0.70 to 1.09) |
| Prior cancer (relative to those without cancer) | 1.35 (0.99 to 1.83) |
| Number of chronic conditions | 1.04 (0.93 to 1.16) |
Women who did not receive further evaluation were censored.
Model adjusted for multiple lumps, history of fibrocystic breast disease, age, BMI, number of chronic conditions, prior history of cancer, race and ethnicity, country of birth, level of education, marital status, insurance status, family history of breast cancer, prior breast biopsy, nulliparity, and site of mammogram.